ACR/ARHP Annual Meeting 2015
Low Incidence of Jaw Osteonecrosis With Prolia, Bisphosphonate Tx
Treatment with Prolia (denosumab) or bisphosphonates was associated with a low incidence rate of potential osteonecrosis of the jaw among postmenopausal women with osteoporosis, according to data presented by Fei Xue, MD, Center for Observational Research, Amgen Inc, at the 2015 ACR/ARHP Annual Meeting.